GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andreas Rosenwald Hermann Einsele |
| Publication date | January 30, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |